This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Pfizer Corporation. Active years: 2016-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2017
Title: Elnaz Menhaji-Klotz: Innovator in Prostaglandin Research
Introduction
Elnaz Menhaji-Klotz is a prominent inventor based in Somerville, MA (US). She has made significant contributions to the field of pharmacology, particularly in the development of antagonists for the prostaglandin EP3 receptor. With a total of 2 patents, her work is paving the way for new therapeutic approaches.
Latest Patents
Elnaz's latest patents focus on antagonists of the prostaglandin EP3 receptor. These patents detail processes for creating these antagonists and methods for administering them to mammals in need. The innovative nature of her work holds promise for advancing medical treatments.
Career Highlights
Elnaz Menhaji-Klotz is currently employed at Pfizer Corporation, a leading global pharmaceutical company. Her role at Pfizer allows her to collaborate with some of the brightest minds in the industry, contributing to groundbreaking research and development.
Collaborations
Some of her notable coworkers include Kevin Barry Bahnck and David James Edmonds. Their collaborative efforts enhance the research environment and foster innovation within the company.
Conclusion
Elnaz Menhaji-Klotz is a trailblazer in the field of prostaglandin research, with her patents reflecting her commitment to advancing medical science. Her work at Pfizer Corporation and collaborations with esteemed colleagues further underscore her impact in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile